The genetic landscape of high-risk neuroblastoma (original) (raw)

Accession codes

Accessions

ArrayExpress

Gene Expression Omnibus

References

1. Maris, J.M. Recent advances in neuroblastoma. N. Engl. J. Med. 362, 2202–2211 (2010).
   Article CAS PubMed PubMed Central Google Scholar
2. Smith, M.A. et al. Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J. Clin. Oncol. 28, 2625–2634 (2010).
   Article PubMed PubMed Central Google Scholar
3. Matthay, K.K. et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-_cis_-retinoic acid. Children's Cancer Group. N. Engl. J. Med. 341, 1165–1173 (1999).
   Article CAS PubMed Google Scholar
4. Yu, A.L. et al. Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma. N. Engl. J. Med. 363, 1324–1334 (2010).
   Article CAS PubMed PubMed Central Google Scholar
5. Oeffinger, K.C. et al. Chronic health conditions in adult survivors of childhood cancer. N. Engl. J. Med. 355, 1572–1582 (2006).
   Article CAS PubMed Google Scholar
6. Trochet, D. et al. Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma. Am. J. Hum. Genet. 74, 761–764 (2004).
   Article CAS PubMed PubMed Central Google Scholar
7. Mosse, Y.P. et al. Germline PHOX2B mutation in hereditary neuroblastoma. Am. J. Hum. Genet. 75, 727–730 (2004).
   Article CAS PubMed PubMed Central Google Scholar
8. Mosse, Y.P. et al. Identification of ALK as a major familial neuroblastoma predisposition gene. Nature 455, 930–935 (2008).
   Article CAS PubMed PubMed Central Google Scholar
9. Janoueix-Lerosey, I. et al. Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma. Nature 455, 967–970 (2008).
   Article CAS PubMed Google Scholar
10. Diskin, S.J. et al. Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma. Nat. Genet. 44, 1126–1130 (2012).
    Article CAS PubMed PubMed Central Google Scholar
11. Wang, K. et al. Integrative genomics identifies LMO1 as a neuroblastoma oncogene. Nature 469, 216–220 (2011).
    Article CAS PubMed Google Scholar
12. Nguyen, L.B. et al. Phenotype restricted genome-wide association study using a gene-centric approach identifies three low-risk neuroblastoma susceptibility loci. PLoS Genet. 7, e1002026 (2011).
    Article CAS PubMed Central Google Scholar
13. Diskin, S.J. et al. Copy number variation at 1q21.1 associated with neuroblastoma. Nature 459, 987–991 (2009).
    Article CAS PubMed PubMed Central Google Scholar
14. Capasso, M. et al. Common variations in BARD1 influence susceptibility to high-risk neuroblastoma. Nat. Genet. 41, 718–723 (2009).
    Article CAS PubMed PubMed Central Google Scholar
15. Maris, J.M. et al. Chromosome 6p22 locus associated with clinically aggressive neuroblastoma. N. Engl. J. Med. 358, 2585–2593 (2008).
    Article CAS PubMed PubMed Central Google Scholar
16. Deyell, R.J. & Attiyeh, E.F. Advances in the understanding of constitutional and somatic genomic alterations in neuroblastoma. Cancer Genet. 204, 113–121 (2011).
    Article CAS PubMed Google Scholar
17. Molenaar, J.J. et al. Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes. Nature 483, 589–593 (2012).
    Article CAS PubMed Google Scholar
18. Cheung, N.-K.V. Association of age at diagnosis and genetic mutations in patients with neuroblastoma. J. Am. Med. Assoc. 307, 1062–1071 (2012).
    Article CAS Google Scholar
19. Sausen, M. et al. Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma. Nat. Genet. 45, 12–17 (2012).
    Article PubMed PubMed Central CAS Google Scholar
20. Bentley, D.R. et al. Accurate whole human genome sequencing using reversible terminator chemistry. Nature 456, 53–59 (2008).
    Article CAS PubMed PubMed Central Google Scholar
21. Drmanac, R. et al. Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays. Science 327, 78–81 (2010).
    Article CAS PubMed Google Scholar
22. Pugh, T.J. et al. Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations. Nature 488, 106–110 (2012).
    Article CAS PubMed PubMed Central Google Scholar
23. Wang, L. et al. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N. Engl. J. Med. 365, 2497–2506 (2011).
    Article CAS PubMed PubMed Central Google Scholar
24. Cancer Genome Atlas Research Network. et al. Comprehensive genomic characterization of squamous cell lung cancers. Nature 489, 519–525 (2012); erratum 491, 288 (2012).
25. Lee, R.S. et al. A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers. J. Clin. Invest. 122, 2983–2988 (2012).
    Article CAS PubMed PubMed Central Google Scholar
26. Banerji, S. et al. Sequence analysis of mutations and translocations across breast cancer subtypes. Nature 486, 405–409 (2012).
    Article CAS PubMed PubMed Central Google Scholar
27. Chapman, M.A. et al. Initial genome sequencing and analysis of multiple myeloma. Nature 471, 467–472 (2011).
    Article CAS PubMed PubMed Central Google Scholar
28. Hodis, E. et al. A landscape of driver mutations in melanoma. Cell 150, 251–263 (2012).
    Article CAS PubMed PubMed Central Google Scholar
29. Imielinski, M. et al. Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell 150, 1107–1120 (2012).
    Article CAS PubMed PubMed Central Google Scholar
30. Stransky, N. et al. The mutational landscape of head and neck squamous cell carcinoma. Science 333, 1157–1160 (2011).
    CAS PubMed PubMed Central Google Scholar
31. Nikolaev, S.I. et al. Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma. Nat. Genet. 44, 133–139 (2012).
    Article CAS Google Scholar
32. Getz, G. et al. Comment on 'The Consensus Coding Sequences of Human Breast and Colorectal Cancers'. Science 317, 1500 (2007).
    Article CAS PubMed Google Scholar
33. Forbes, S.A. et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res. 39, D945–D950 (2011).
    Article CAS PubMed Google Scholar
34. Shi, L. et al. The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat. Biotechnol. 28, 827–838 (2010).
    Article CAS PubMed Google Scholar
35. George, R.E. et al. Activating mutations in ALK provide a therapeutic target in neuroblastoma. Nature 455, 975–978 (2008).
    Article CAS PubMed PubMed Central Google Scholar
36. Chen, Y. et al. Oncogenic mutations of ALK kinase in neuroblastoma. Nature 455, 971–974 (2008).
    Article CAS PubMed Google Scholar
37. Bentires-Alj, M. et al. Activating mutations of the Noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia. Cancer Res. 64, 8816–8820 (2004).
    Article CAS PubMed Google Scholar
38. Tartaglia, M. et al. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat. Genet. 29, 465–468 (2001).
    Article CAS PubMed Google Scholar
39. Tartaglia, M. et al. Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat. Genet. 34, 148–150 (2003).
    Article CAS PubMed Google Scholar
40. Sarkozy, A. et al. A novel PTPN11 gene mutation bridges Noonan syndrome, multiple lentigines/LEOPARD syndrome and Noonan-like/multiple giant cell lesion syndrome. Eur. J. Hum. Genet. 12, 1069–1072 (2004).
    Article CAS PubMed Google Scholar
41. De Brouwer, S. et al. Meta-analysis of neuroblastomas reveals a skewed ALK mutation spectrum in tumors with MYCN amplification. Clin. Cancer Res. 16, 4353–4362 (2010).
    Article CAS PubMed Google Scholar
42. Brodeur, G.M., Seeger, R.C., Schwab, M., Varmus, H.E. & Bishop, J.M. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224, 1121–1124 (1984).
    Article CAS PubMed Google Scholar
43. Adzhubei, I.A. et al. A method and server for predicting damaging missense mutations. Nat. Methods 7, 248–249 (2010).
    Article CAS PubMed PubMed Central Google Scholar
44. Ng, P.C. & Henikoff, S. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res. 31, 3812–3814 (2003).
    Article CAS PubMed PubMed Central Google Scholar
45. Schwarz, J.M., Rödelsperger, C., Schuelke, M. & Seelow, D. MutationTaster evaluates disease-causing potential of sequence alterations. Nat. Methods 7, 575–576 (2010).
    Article CAS PubMed Google Scholar
46. Tavtigian, S.V. et al. Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral. J. Med. Genet. 43, 295–305 (2006).
    Article CAS PubMed Google Scholar
47. Marchler-Bauer, A. et al. CDD: a Conserved Domain Database for the functional annotation of proteins. Nucleic Acids Res. 39, D225–D229 (2011).
    Article CAS PubMed Google Scholar
48. Love, C. et al. The genetic landscape of mutations in Burkitt lymphoma. Nat. Genet. 44, 1321–1325 (2012).
    Article CAS PubMed PubMed Central Google Scholar
49. Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545–15550 (2005).
    Article CAS PubMed PubMed Central Google Scholar
50. Barbosa-Morais, N.L., Carmo-Fonseca, M. & Aparício, S. Systematic genome-wide annotation of spliceosomal proteins reveals differential gene family expansion. Genome Res. 16, 66–77 (2006).
    Article CAS PubMed PubMed Central Google Scholar
51. Chen, M. & Manley, J.L. Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches. Nat. Rev. Mol. Cell Biol. 10, 741–754 (2009).
    Article CAS PubMed PubMed Central Google Scholar
52. Gabut, M., Chaudhry, S. & Blencowe, B.J. SnapShot: The splicing regulatory machinery. Cell 133, 192 e1 (2008).
    Article CAS PubMed Google Scholar
53. Futreal, P.A. et al. A census of human cancer genes. Nat. Rev. Cancer 4, 177–183 (2004).
    Article CAS PubMed PubMed Central Google Scholar
54. Sijmons, R.H. Encyclopaedia of tumour-associated familial disorders. Part I: from AIMAH to CHIME syndrome. Hered. Cancer Clin. Pract. 6, 22–57 (2008).
    Article PubMed PubMed Central Google Scholar
55. Wood, R.D., Mitchell, M. & Lindahl, T. Human DNA repair genes, 2005. Mutat. Res. 577, 275–283 (2005).
    Article CAS PubMed Google Scholar
56. Tennessen, J.A. et al. Evolution and functional impact of rare coding variation from deep sequencing of human exomes. Science 337, 64–69 (2012).
    CAS PubMed PubMed Central Google Scholar
57. Sodha, N., Mantoni, T.S., Tavtigian, S.V., Eeles, R. & Garrett, M.D. Rare germ line CHEK2 variants identified in breast cancer families encode proteins that show impaired activation. Cancer Res. 66, 8966–8970 (2006).
    Article CAS PubMed Google Scholar
58. Lee, S.B. et al. Destabilization of CHK2 by a missense mutation associated with Li-Fraumeni syndrome. Cancer Res. 61, 8062–8067 (2001).
    CAS PubMed Google Scholar
59. Dong, X. et al. Mutations in CHEK2 associated with prostate cancer risk. Am. J. Hum. Genet. 72, 270–280 (2003).
    Article CAS PubMed PubMed Central Google Scholar
60. Petitjean, A. et al. Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum. Mutat. 28, 622–629 (2007).
    Article CAS PubMed Google Scholar
61. Birch, J.M. et al. Relative frequency and morphology of cancers in carriers of germline TP53 mutations. Oncogene 20, 4621–4628 (2001).
    Article CAS PubMed Google Scholar
62. Choi, J.M. et al. Analysis of PARK genes in a Korean cohort of early-onset Parkinson disease. Neurogenetics 9, 263–269 (2008).
    Article CAS PubMed Google Scholar
63. Marongiu, R. et al. PINK1 heterozygous rare variants: prevalence, significance and phenotypic spectrum. Hum. Mutat. 29, 565 (2008).
    Article PubMed Google Scholar
64. Klein, C. et al. PINK1, Parkin, and DJ-1 mutations in Italian patients with early-onset parkinsonism. Eur. J. Hum. Genet. 13, 1086–1093 (2005).
    Article CAS PubMed Google Scholar
65. Fredlund, E., Ringnér, M., Maris, J.M. & Påhlman, S. High Myc pathway activity and low stage of neuronal differentiation associate with poor outcome in neuroblastoma. Proc. Natl. Acad. Sci. USA 105, 14094–14099 (2008).
    Article CAS PubMed PubMed Central Google Scholar
66. Storlazzi, C.T. et al. Gene amplification as double minutes or homogeneously staining regions in solid tumors: origin and structure. Genome Res. 20, 1198–1206 (2010).
    Article CAS PubMed PubMed Central Google Scholar
67. Stephens, P.J. et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 144, 27–40 (2011).
    Article CAS PubMed PubMed Central Google Scholar
68. Krzywinski, M. et al. Circos: an information aesthetic for comparative genomics. Genome Res. 19, 1639–1645 (2009).
    CAS PubMed PubMed Central Google Scholar
69. Gnirke, A. et al. Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing. Nat. Biotechnol. 27, 182–189 (2009).
    Article CAS PubMed PubMed Central Google Scholar
70. Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754–1760 (2009).
    Article CAS PubMed PubMed Central Google Scholar
71. Goya, R. et al. SNVMix: predicting single nucleotide variants from next-generation sequencing of tumors. Bioinformatics 26, 730–736 (2010).
    Article CAS PubMed PubMed Central Google Scholar
72. Carnevali, P. et al. Computational techniques for human genome resequencing using mated gapped reads. J. Comput. Biol. 19, 279–292 (2012).
    Article CAS PubMed Google Scholar
73. Kostic, A.D. et al. PathSeq: software to identify or discover microbes by deep sequencing of human tissue. Nat. Biotechnol. 29, 393–396 (2011).
    Article CAS PubMed PubMed Central Google Scholar
74. Robertson, G. et al. De novo assembly and analysis of RNA-seq data. Nat. Methods 7, 909–912 (2010).
    Article CAS PubMed Google Scholar
75. Lee, W. et al. The mutation spectrum revealed by paired genome sequences from a lung cancer patient. Nature 465, 473–477 (2010).
    Article CAS PubMed Google Scholar
76. Morin, R.D. et al. Somatic mutation of EZH2 (Y641) in follicular and diffuse large B-cell lymphomas of germinal center origin. Nat. Genet. 42, 181–185 (2010).
    Article CAS PubMed PubMed Central Google Scholar
77. Morin, R.D. et al. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 476, 298–303 (2011).
    Article CAS PubMed PubMed Central Google Scholar
78. Pruitt, K.D., Tatusova, T., Klimke, W. & Maglott, D.R. NCBI Reference Sequences: current status, policy and new initiatives. Nucleic Acids Res. 37, D32–D36 (2009).
    Article CAS PubMed Google Scholar
79. Morozova, O. et al. System-level analysis of neuroblastoma tumor–initiating cells implicates AURKB as a novel drug target for neuroblastoma. Clin. Cancer Res. 16, 4572–4582 (2010).
    Article CAS PubMed Google Scholar
80. Morin, R. et al. Profiling the HeLa S3 transcriptome using randomly primed cDNA and massively parallel short-read sequencing. Biotechniques 45, 81–94 (2008).
    Article CAS PubMed Google Scholar
81. Li, H. et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078–2079 (2009).
    Article PubMed PubMed Central CAS Google Scholar
82. Robinson, J.T. et al. Integrative genomics viewer. Nat. Biotechnol. 29, 24–26 (2011).
    Article CAS PubMed PubMed Central Google Scholar
83. Ye, K., Schulz, M.H., Long, Q., Apweiler, R. & Ning, Z. Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads. Bioinformatics 25, 2865–2871 (2009).
    Article CAS PubMed PubMed Central Google Scholar
84. Shah, S.P. et al. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature 461, 809–813 (2009).
    Article CAS PubMed Google Scholar
85. Simpson, J.T. et al. ABySS: a parallel assembler for short read sequence data. Genome Res. 19, 1117–1123 (2009).
    Article CAS PubMed PubMed Central Google Scholar
86. Pruitt, K.D. et al. The consensus coding sequence (CCDS) project: identifying a common protein-coding gene set for the human and mouse genomes. Genome Res. 19, 1316–1323 (2009).
    Article CAS PubMed PubMed Central Google Scholar
87. Mortazavi, A., Williams, B.A., McCue, K., Schaeffer, L. & Wold, B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat. Methods 5, 621–628 (2008).
    Article CAS PubMed Google Scholar
88. Griffith, M. et al. Alternative expression analysis by RNA sequencing. Nat. Methods 7, 843–847 (2010).
    Article CAS PubMed Google Scholar
89. Su, A.I. et al. Large-scale analysis of the human and mouse transcriptomes. Proc. Natl. Acad. Sci. USA 99, 4465–4470 (2002).
    Article CAS PubMed PubMed Central Google Scholar

Download references

Acknowledgements

We thank the Children's Oncology Group for the collection and annotation of samples for this study, and all TARGET co-investigators for scientific support of this project. Funding was provided by US National Institutes of Health grants CA98543 and CA98413 to the Children's Oncology Group, RC1MD004418 to the TARGET consortium, CA124709 (J.M.M.) and CA060104 (R.C.S.) and National Human Genome Research Institute grant U54HG003067 (E.S.L., D.A., S.B.G., G.G. and M.M.), as well as a contract from the National Cancer Institute, US National Institutes of Health (HHSN261200800001E). Additional support included a Canadian Institutes of Health Research Fellowship (T.J.P.), a Roman M. Babicki Fellowship in Medical Research at the University of British Columbia (O.M.), the Canada Research Chair in Genome Science (M.A.M.), the Giulio D'Angio Endowed Chair (J.M.M.), the Alex's Lemonade Stand Foundation (J.M.M.), the Arms Wide Open Foundation (J.M.M.) and the Cookies for Kids Foundation (J.M.M.). We thank E. Nickerson, S. Channer, K. Novik, C. Suragh and R. Roscoe for project management support. We also thank the staff of the Genome Sciences Centre Biospecimen Core, Library Construction, Sequencing and Bioinformatics teams, and the staff of the Broad Institute Biological Samples, Genome Sequencing and Genetic Analysis Platforms for their expertise in genomic processing of samples, and generating the sequencing data used in this analysis.

Author information

Author notes

1. Trevor J Pugh and Olena Morozova: These authors contributed equally to this work.

Authors and Affiliations

1. The Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA
   Trevor J Pugh, Daniel Auclair, Scott L Carter, Kristian Cibulskis, Megan Hanna, Adam Kiezun, Jaegil Kim, Michael S Lawrence, Lee Lichenstein, Aaron McKenna, Chandra Sekhar Pedamallu, Alex H Ramos, Erica Shefler, Andrey Sivachenko, Carrie Sougnez, Chip Stewart, Eric S Lander, Stacey B Gabriel, Gad Getz & Matthew Meyerson
2. Harvard Medical School, Boston, Massachusetts, USA
   Trevor J Pugh, Alex H Ramos, Wendy B London & Matthew Meyerson
3. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA
   Trevor J Pugh, Megan Hanna, Chandra Sekhar Pedamallu & Matthew Meyerson
4. Genome Sciences Centre, British Columbia Cancer Agency, University of British Columbia, Vancouver, British Columbia, Canada
   Olena Morozova, Adrian Ally, Inanc Birol, Readman Chiu, Richard D Corbett, Martin Hirst, Shaun D Jackman, Baljit Kamoh, Alireza Hadj Khodabakshi, Martin Krzywinski, Allan Lo, Richard A Moore, Karen L Mungall, Jenny Qian, Angela Tam, Nina Thiessen, Yongjun Zhao, Steven J M Jones & Marco A Marra
5. Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada
   Olena Morozova & Marco A Marra
6. Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
   Edward F Attiyeh, Kristina A Cole, Maura Diamond, Sharon J Diskin, Yael P Mosse, Andrew C Wood, Michael D Hogarty & John M Maris
7. Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
   Edward F Attiyeh, Kristina A Cole, Maura Diamond, Sharon J Diskin, Yael P Mosse, Andrew C Wood, Michael D Hogarty & John M Maris
8. Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
   Edward F Attiyeh, Kristina A Cole, Maura Diamond, Sharon J Diskin, Yael P Mosse, Andrew C Wood, Michael D Hogarty & John M Maris
9. Division of Hematology/Oncology, The Children's Hospital Los Angeles, Los Angeles, California, USA
   Shahab Asgharzadeh, Lingyun Ji, Richard Sposto & Robert C Seeger
10. Saban Research Institute, The Children's Hospital Los Angeles, Los Angeles, California, USA
    Shahab Asgharzadeh, Lingyun Ji, Richard Sposto & Robert C Seeger
11. Keck School of Medicine, University of Southern California, Los Angeles, California, USA
    Shahab Asgharzadeh, Lingyun Ji, Richard Sposto & Robert C Seeger
12. Pediatric Oncology Branch, Oncogenomics Section, Center for Cancer Research, National Institutes of Health, Gaithersburg, Maryland, USA
    Jun S Wei, Thomas Badgett & Javed Khan
13. Children's Hospital Boston/Dana-Farber Cancer Institute and Children's Oncology Group, Boston, Massachusetts, USA
    Wendy B London
14. Biopathology Center, Nationwide Children's Hospital, Columbus, Ohio, USA
    Yvonne Moyer & Julie M Gastier-Foster
15. The Ohio State University College of Medicine, Columbus, Ohio, USA
    Yvonne Moyer & Julie M Gastier-Foster
16. Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland, USA
    Malcolm A Smith
17. Office of Cancer Genomics, National Cancer Institute, Bethesda, Maryland, USA
    Jaime M Guidry Auvil & Daniela S Gerhard
18. Abramson Family Cancer Research Institute, Philadelphia, Pennsylvania, USA
    John M Maris

Authors

1. Trevor J Pugh
   You can also search for this author inPubMed Google Scholar
2. Olena Morozova
   You can also search for this author inPubMed Google Scholar
3. Edward F Attiyeh
   You can also search for this author inPubMed Google Scholar
4. Shahab Asgharzadeh
   You can also search for this author inPubMed Google Scholar
5. Jun S Wei
   You can also search for this author inPubMed Google Scholar
6. Daniel Auclair
   You can also search for this author inPubMed Google Scholar
7. Scott L Carter
   You can also search for this author inPubMed Google Scholar
8. Kristian Cibulskis
   You can also search for this author inPubMed Google Scholar
9. Megan Hanna
   You can also search for this author inPubMed Google Scholar
10. Adam Kiezun
    You can also search for this author inPubMed Google Scholar
11. Jaegil Kim
    You can also search for this author inPubMed Google Scholar
12. Michael S Lawrence
    You can also search for this author inPubMed Google Scholar
13. Lee Lichenstein
    You can also search for this author inPubMed Google Scholar
14. Aaron McKenna
    You can also search for this author inPubMed Google Scholar
15. Chandra Sekhar Pedamallu
    You can also search for this author inPubMed Google Scholar
16. Alex H Ramos
    You can also search for this author inPubMed Google Scholar
17. Erica Shefler
    You can also search for this author inPubMed Google Scholar
18. Andrey Sivachenko
    You can also search for this author inPubMed Google Scholar
19. Carrie Sougnez
    You can also search for this author inPubMed Google Scholar
20. Chip Stewart
    You can also search for this author inPubMed Google Scholar
21. Adrian Ally
    You can also search for this author inPubMed Google Scholar
22. Inanc Birol
    You can also search for this author inPubMed Google Scholar
23. Readman Chiu
    You can also search for this author inPubMed Google Scholar
24. Richard D Corbett
    You can also search for this author inPubMed Google Scholar
25. Martin Hirst
    You can also search for this author inPubMed Google Scholar
26. Shaun D Jackman
    You can also search for this author inPubMed Google Scholar
27. Baljit Kamoh
    You can also search for this author inPubMed Google Scholar
28. Alireza Hadj Khodabakshi
    You can also search for this author inPubMed Google Scholar
29. Martin Krzywinski
    You can also search for this author inPubMed Google Scholar
30. Allan Lo
    You can also search for this author inPubMed Google Scholar
31. Richard A Moore
    You can also search for this author inPubMed Google Scholar
32. Karen L Mungall
    You can also search for this author inPubMed Google Scholar
33. Jenny Qian
    You can also search for this author inPubMed Google Scholar
34. Angela Tam
    You can also search for this author inPubMed Google Scholar
35. Nina Thiessen
    You can also search for this author inPubMed Google Scholar
36. Yongjun Zhao
    You can also search for this author inPubMed Google Scholar
37. Kristina A Cole
    You can also search for this author inPubMed Google Scholar
38. Maura Diamond
    You can also search for this author inPubMed Google Scholar
39. Sharon J Diskin
    You can also search for this author inPubMed Google Scholar
40. Yael P Mosse
    You can also search for this author inPubMed Google Scholar
41. Andrew C Wood
    You can also search for this author inPubMed Google Scholar
42. Lingyun Ji
    You can also search for this author inPubMed Google Scholar
43. Richard Sposto
    You can also search for this author inPubMed Google Scholar
44. Thomas Badgett
    You can also search for this author inPubMed Google Scholar
45. Wendy B London
    You can also search for this author inPubMed Google Scholar
46. Yvonne Moyer
    You can also search for this author inPubMed Google Scholar
47. Julie M Gastier-Foster
    You can also search for this author inPubMed Google Scholar
48. Malcolm A Smith
    You can also search for this author inPubMed Google Scholar
49. Jaime M Guidry Auvil
    You can also search for this author inPubMed Google Scholar
50. Daniela S Gerhard
    You can also search for this author inPubMed Google Scholar
51. Michael D Hogarty
    You can also search for this author inPubMed Google Scholar
52. Steven J M Jones
    You can also search for this author inPubMed Google Scholar
53. Eric S Lander
    You can also search for this author inPubMed Google Scholar
54. Stacey B Gabriel
    You can also search for this author inPubMed Google Scholar
55. Gad Getz
    You can also search for this author inPubMed Google Scholar
56. Robert C Seeger
    You can also search for this author inPubMed Google Scholar
57. Javed Khan
    You can also search for this author inPubMed Google Scholar
58. Marco A Marra
    You can also search for this author inPubMed Google Scholar
59. Matthew Meyerson
    You can also search for this author inPubMed Google Scholar
60. John M Maris
    You can also search for this author inPubMed Google Scholar

Contributions

J.M.M., J. Khan, R.C.S., D.S.G. and M.A.S. conceived and led the project. M.A.M. and M.M. conceived of and supervised all aspects of the sequencing work at the British Columbia (BC) Cancer Agency Genome Sciences Centre and Broad Institute, respectively. T.J.P. and O.M. performed the analyses and interpreted the results. E.F.A., S.A., J.S.W., K.A.C., M.D., S.J.D., A.C.W., Y.P.M., L.J., T.B., Y.M., J.M.G.-F. and M.D.H. selected and characterized samples, provided disease-specific expertise in data analysis and edited the manuscript. R.S. and W.B.L. provided statistical support and analyses of clinical covariates. D.A., E.S., C. Sougnez, M.D. and J.M.G.A. provided overall project management and quality control support. S.L.C., K.C., M. Hanna, A.K., J. Kim, M.S.L., L.L., A.M., A.H.R., A.S. and C. Stewart supported analysis of somatic and germline alterations in the exome sequencing data. C.S.P. performed the pathogen discovery analysis. I.B., K.L.M., R.C., S.D.J. and J.Q. performed de novo assembly of Illumina sequencing data. Y.Z. led the library construction effort for the Illumina libraries. A.T. and Y.Z. planned the sequencing verification, and A.A. and B.K. performed the experiments. R.D.C. performed copy number analysis of genome sequencing data. M.K. performed verification of candidate rearrangements. N.T. performed gene- and exon-level quantification analysis of RNA-seq data. A.L. and A.H.K. helped interpret data provided by Complete Genomics. R.A.M. and M. Hirst led the sequencing effort for the Illumina genome and transcriptome libraries. S.B.G. and E.S.L. led the sequencing effort for the exome sequencing libraries. G.G. and S.J.M.J. supervised the bioinformatics group at the Broad Institute and BC Cancer Agency Genome Sciences Centre, respectively. T.J.P., O.M., D.S.G., M.A.M., M.M. and J.M.M. cowrote the manuscript with input from all coauthors.

Corresponding authors

Correspondence toMarco A Marra, Matthew Meyerson or John M Maris.

Ethics declarations

Competing interests

M.M. is a paid consultant for and equity holder in Foundation Medicine, a genomics-based oncology diagnostics company, and is a paid consultant for Novartis.

Supplementary information

Supplementary Text and Figures

Supplementary Note, Supplementary Tables 11–14 and Supplementary Figures 1–10 (PDF 4034 kb)

Supplementary Table 1

Master data table: Clinical and molecular data for all neuroblastoma cases including identifiers from other databases, sequencing technologies used, clinical and biological covariates, and matrix of mutation calls (XLSX 2887 kb)

Supplementary Table 2

Coverage: Fraction of bases in each exon with sufficient coverage for mutation detection (XLSX 184212 kb)

Supplementary Table 3

Full mutation list: All coding somatic mutations called in all cases (XLSX 2377 kb)

Supplementary Table 4

Mutation frequency correlates: Statistical comparison of mutation frequency distributions (Kolmogorov-Smirnov) when comparing cases by clinical and biological variables (XLSX 37 kb)

Supplementary Table 5

Pathogens: Counts of sequencing reads in exome capture libraries corresponding to known viruses (XLS 49 kb)

Supplementary Table 6

MutSig: Significance analysis of somatic mutation frequency in all genes and a focused set of genes listed in the Catalogue of Somatic Mutations in Cancer (XLSX 2052 kb)

Supplementary Table 7

Gene set significance analysis: Full list of pathways, member genes, mutated genes, and significance values as calculated by MutSig with and without significantly mutated genes (XLSX 381 kb)

Supplementary Table 8

Structural rearrangements: All structural variants detected in neuroblastoma genomes or transcriptomes (XLSX 16 kb)

Supplementary Table 9

Significance analysis of germline ClinVar variation: List of all genes tested for enrichment in neuroblastoma of ClinVar variants (XLSX 1622 kb)

Supplementary Table 10

Significance analysis of germline loss-of-function variants in Cancer Census, cancer syndrome, or DNA repair genes (XLSX 632 kb)

Rights and permissions

About this article

Cite this article

Pugh, T., Morozova, O., Attiyeh, E. et al. The genetic landscape of high-risk neuroblastoma.Nat Genet 45, 279–284 (2013). https://doi.org/10.1038/ng.2529

Download citation

• Received: 27 September 2012
• Accepted: 20 December 2012
• Published: 20 January 2013
• Issue Date: March 2013
• DOI: https://doi.org/10.1038/ng.2529